SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-18-008553
Filing Date
2018-11-06
Accepted
2018-11-06 06:21:28
Documents
67
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q qure-20180930x10q.htm 10-Q 2000030
2 EX-31.1 qure-20180930ex311ce219b.htm EX-31.1 18166
3 EX-31.2 qure-20180930ex3121b5faf.htm EX-31.2 18063
4 EX-32.1 qure-20180930ex3212bb999.htm EX-32.1 11138
  Complete submission text file 0001558370-18-008553.txt   7324667

Data Files

Seq Description Document Type Size
5 EX-101.INS qure-20180930.xml EX-101.INS 1564838
6 EX-101.SCH qure-20180930.xsd EX-101.SCH 53249
7 EX-101.CAL qure-20180930_cal.xml EX-101.CAL 48888
8 EX-101.DEF qure-20180930_def.xml EX-101.DEF 231570
9 EX-101.LAB qure-20180930_lab.xml EX-101.LAB 491829
10 EX-101.PRE qure-20180930_pre.xml EX-101.PRE 374982
Mailing Address PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP
Business Address PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP 1-339-970-7000
uniQure N.V. (Filer) CIK: 0001590560 (see all company filings)

IRS No.: 000000000
Type: 10-Q | Act: 34 | File No.: 001-36294 | Film No.: 181161422
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences